High income vs Malta: Cause of death, by non-communicable diseases, ages 15-59, male
High income
62.6%
in 2021
Malta
74.9%
in 2021
High income rank
11th
Malta rank
14th
Cause of death, by non-communicable diseases, ages 15-59, male over time
- High income
- Malta
How they compare
Malta currently reports 74.9% against 62.6% in High income, a difference of 12.3%.
That makes Malta's figure about 1.2 times High income's.
Across all 6 years both countries report, Malta has been ahead every year.
High income ranks 11th and Malta ranks 14th of 47 groups.
Malta has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | High income | Malta | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 65.1% | 77.3% | 12.2% | Malta |
| 2010s | 70.4% | 77.1% | 6.7% | Malta |
| 2020s | 64.4% | 74.7% | 10.3% | Malta |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, male, High income or Malta?
- Malta, at 74.9% against 62.6% in High income as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, male between High income and Malta?
- 12.3%, with Malta ahead.
- How many years of comparable data are there for High income and Malta?
- 6 years are reported by both, from 2000 to 2021.
- How do High income and Malta rank globally for cause of death, by non-communicable diseases, ages 15-59, male?
- High income ranks 11th and Malta ranks 14th of 47 groups.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, male (% of total male deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 15-59 due to non-communicable diseases divided by number of all male deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.